- 'Grade' isn't about the molecule. Research tirzepatide and Mounjaro contain the same peptide; the difference is everything that has been proven about the finished product.
- A licensed medicine is manufactured under GMP, released batch-by-batch by a Qualified Person, tested for sterility, endotoxin and stability, and monitored after sale. A research compound is tested for identity, purity and quantity.
- ‘Pharmaceutical grade’ has no legal meaning on a research-chemical listing. Without a GMP certificate and a pharmacopoeial monograph, it's decoration.
- The honest description of a good research peptide is 'research grade, made and tested well' — which is exactly what a certificate and an independent report let you check.
"Is research-grade tirzepatide the same as Mounjaro?" is a fair question with a two-part answer: the molecule, yes; the product, no. The gap between those two answers is what "grade" means, and it's worth understanding because vendor pages use the word as if it were a purity tier. It isn't.
The molecule and the product
Tirzepatide is a specific 39-residue peptide with a specific mass. Any laboratory that can synthesise and purify it can produce material that is, chemically, tirzepatide. Mounjaro is a licensed medicine containing that molecule: a defined formulation, in a defined device, made by a named manufacturer under a defined process, with a defined shelf life, authorised by the MHRA for defined uses.
Everything in the second sentence after "containing that molecule" is what a research compound doesn't have. Not because research material is inferior by nature, but because none of it has been demonstrated and none of it has been certified.
What a licensed medicine has that a research compound doesn't
| Licensed medicine | Research compound | |
|---|---|---|
| Manufacturing standard | Good Manufacturing Practice (GMP), inspected and certified | Manufacturer's own system — may be excellent, isn't inspected against GMP for this product |
| Batch release | Each batch certified by a Qualified Person before it can be sold | Manufacturer's certificate of analysis |
| Identity, purity, quantity | Tested against a registered specification | Tested — this is what a CoA and an independent report cover |
| Sterility and endotoxin | Tested and specified for every batch | Not usually reported |
| Particulates, pH, osmolality | Specified for injectable products | Not usually reported |
| Stability data | Real-time and accelerated studies support the labelled shelf life | Shelf life stated by the manufacturer |
| Device validation | The pen is a regulated medical device with its own dossier | The pen is packaging |
| Clinical evidence | Trials in humans support the licensed uses | Whatever exists in the literature — for some compounds, none |
| Post-market monitoring | Adverse-event reporting, recalls, pharmacovigilance | None |
None of the right-hand column is a criticism of research material. It's a description of what "research grade" means: a compound whose identity, purity and quantity can be verified, supplied for laboratory work, with nothing else claimed.
"Pharmaceutical grade" on a vendor page
Now the phrase that started this. On a genuine pharmaceutical supply chain, "pharmaceutical grade" means a substance that meets a pharmacopoeial monograph — a published specification in the British, European or US Pharmacopoeia — and was made under GMP with the paperwork to prove it. Retatrutide has no monograph; it's investigational. Tirzepatide's pharmacopoeial status is tied to the licensed product's own dossier, not to a public specification a third party can claim compliance with.
So on a research-chemical listing, "pharmaceutical grade" cannot mean what it means in pharmacy. What it usually means is "high purity", which is a different claim with a different name, and which a certificate can support directly. A vendor who uses the bigger phrase instead of the checkable one is choosing impression over evidence. It's on our checklist as a red flag for that reason.
Why the distinction matters more, not less, for an unlicensed compound
With a licensed medicine, the regulator has done the checking and the buyer needs only a prescription. With a research compound, nobody has checked on the buyer's behalf, so the documents are the assurance:
- The manufacturer's certificate tells you the batch's identity, purity and — if it's a good one — quantity. How to read it.
- The independent report tells you the same things from an unconnected lab, and lets you verify it by key. What it proves and what it doesn't.
- Batch traceability ties both to the carton in your hand.
- The manufacturer's identity — a named facility in a named country with a quality system — is what stands in for GMP certification.
A buyer who has those four things knows more about their research compound than most people know about their prescriptions. A buyer who has a photograph of a pen and the phrase "pharmaceutical grade" knows nothing.
The seizures, in this light
The MHRA's 2025–26 operations found pens labelled as tirzepatide and retatrutide being filled in a warehouse and a country estate. Those products were, in the regulator's language, unlicensed medicines: presented for human use, with no authorisation, from no recognised manufacturer. They were also — and this is the point — not research compounds in any meaningful sense either, because nothing about them was traceable or tested. "Research grade" was a label on the box, not a description of the contents.
The two honest categories are licensed medicine and research compound, made and tested well. Everything else is a label.
How Biovanta describes its products
Research grade. Manufactured in Switzerland by a named facility, tested per batch by the manufacturer, with an independent Janoshik report published per batch as each completes on the testing page. Not a medicine, not "pharmaceutical grade", not for human or veterinary use — supplied strictly for in-vitro laboratory research. Tirzepatide is available as a licensed medicine in the UK under the name Mounjaro, through a prescriber; research tirzepatide is not that product.
The research peptides hub collects what we publish on this, product by product.
Sources
Questions this article answers
Is research-grade tirzepatide the same as Mounjaro?
The molecule is the same; the product is not. Mounjaro is a licensed medicine made under GMP, released batch-by-batch, tested for sterility and endotoxin, supported by stability and clinical data and monitored after sale. Research tirzepatide is a laboratory compound verified for identity, purity and quantity, and is not a medicine.
What does ‘pharmaceutical grade’ mean on a peptide listing?
Legally, nothing. In pharmacy the phrase means compliance with a pharmacopoeial monograph under GMP, with documentation. Retatrutide has no monograph and no research vendor holds a GMP certificate for these products, so on a listing the phrase is a marketing description, not a standard.
What is a research-grade peptide actually tested for?
Identity (the measured mass matches the compound), purity (by HPLC, as a percentage of the main peak) and, on a good certificate or an independent report, quantity. Sterility, endotoxin, heavy metals and stability are part of a licensed medicine's specification and are not usually reported for research material.
Want the certificate for a real batch?
Name a compound and we'll send the certificate for the batch you would receive — before you order, no account needed.